Correction: Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl
Juliano D. Paccez,
Kristal Duncan,
Durairaj Sekar,
Ricardo G. Correa,
Yihong Wang,
Xuesong Gu,
Manoj Bashin,
Kelly Chibale,
Towia A. Libermann,
Luiz F. Zerbini
Affiliations
Juliano D. Paccez
International Centre for Genetic Engineering and Biotechnology (ICGEB)
Kristal Duncan
International Centre for Genetic Engineering and Biotechnology (ICGEB)
Durairaj Sekar
International Centre for Genetic Engineering and Biotechnology (ICGEB)
Ricardo G. Correa
Sanford Burnham Prebys Medical Discovery Institute
Yihong Wang
Department of Pathology and Laboratory Medicine, Warren Alpert School of Medicine, Brown University
Xuesong Gu
BIDMC Genomics, Proteomics, Bioinformatics and Systems Biology Center, Beth Israel Deaconess Medical Center and Harvard Medical School
Manoj Bashin
BIDMC Genomics, Proteomics, Bioinformatics and Systems Biology Center, Beth Israel Deaconess Medical Center and Harvard Medical School
Kelly Chibale
South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Towia A. Libermann
BIDMC Genomics, Proteomics, Bioinformatics and Systems Biology Center, Beth Israel Deaconess Medical Center and Harvard Medical School
Luiz F. Zerbini
International Centre for Genetic Engineering and Biotechnology (ICGEB)
